Hooia moho peptide: 5-Ke alakaʻi hōʻoia pae

Pane wikiwiki

Verify AI-designed peptides in 5 stages: ʻike a me ka maʻemaʻe, CD folding, stability and aggregation, activity thresholds, a me ka ho'āʻo endotoxin.

No ke aha e hoʻoholo ai ka hōʻoia o ka moho peptide i nā kaʻina e hoʻohui ʻia

ʻAʻole hōʻike hoʻokolohua ka hilinaʻi helu helu. Nā hōʻailona o ka hoʻolālā peptide generative Ua ʻike ʻo nā mea hoʻohālike hoʻolālā e hoʻonui i ko lākou hilinaʻi ponoʻī a hiki ke kuhi hewa i nā peptides ʻoiai ke nānā pono ʻia ka laʻana o ka iwi kuamoʻo.. He ākea ka ʻokoʻa ma waena o ka wānana a me ka ʻoiaʻiʻo: ʻO nā hoʻolaha binder mua de novo mai 0.5% holomua hana no ka influenza HA binders i 26% no ka botulinum neurotoxin B binders, me de novo SARS-CoV-2 miniprotein inhibitors ma 0.1% (Huang et al., 2024).

Hooia moho peptide: 5-Ke alakaʻi hōʻoia pae

ʻO ia ke kumu e hana ai ka hōʻoia ʻana o ka moho peptide ma ke ʻano he make-point sequence ma mua o kahi papa inoa. Loaʻa kēlā me kēia pae ma lalo e hoʻopau i kahi moho ma mua o ke kumu kūʻai hou aku: ʻike a me ka maʻemaʻe, alaila pelu, a laila kūpaʻa, a laila hana, a laila endotoxin a me ka manufacturability. ʻAʻole lawe ʻia ka moho i hāʻule i ka puka mua.

Ke kahua 1: E hōʻoia i ka ʻike a me ka maʻemaʻe ma mua o nā mea ʻē aʻe

kahi chromatogram RP-HPLC i uhi ʻia a hoʻokaʻawale ʻia ka spectrum nui ESI no hoʻokahi peptide lot, me ka piko nui, he poʻohiwi holoi ʻoki ʻia, a me t

ʻO ka maʻemaʻe a me ka maʻemaʻe chromatographic ka mea pepehi maʻalahi loa i ka hōʻoia moho peptide, a pono e hoʻomaʻemaʻe ʻia ma mua o kekahi hana pelupi a hana paha. E kūkulu i ka nuipaʻa i manaʻo ʻia i loko o ka theoretical mass ma mua o kou hoʻohālikelike ʻana: hoʻohui acetylation +42.01 A, Hoʻokaʻawale ka C-terminal amidation 0.98 A, e unuhi kēlā me kēia palapala hoʻopaʻa disulfide 2.02 A, a me ke poo-a-huelo cyclization unuhi 18.01 A (Mea hoʻomohala proteomics, 2025). Ma LC-MS me ESI-TOF, ʻO nā ʻōnaehana i hoʻoponopono maikaʻi ʻia e hoʻoholo i ka nuipaʻa i ʻike ʻia i kahi ʻano 3 i 5 ppm a me nā mea kani maʻamau i 5 i 15 ppm; ʻO MALDI-TOF ka pololei me ka calibration kūloko 10 ppm, hoʻohaʻahaʻa i ke ʻano ʻano 100 ppm a i ʻole ka ʻino ma waho (ʻO Iowa State Protein Facility, 2025).

ʻO ka maʻemaʻe RP-HPLC he wahi-pakeneka ma 214 nm, ʻo ia hoʻi ka ʻāpana piko nui i puʻunaue ʻia e ka ʻāpana kiʻekiʻe UV i hoʻohui ʻia, a hoʻololi ia me ke ʻano a me ka lōʻihi o ka nalu (Mea hoʻomohala proteomics, 2025). ʻAʻole ia he ʻano peptide ʻoiaʻiʻo. ʻO ka ʻikepili peptide Net ka helu no ka wai, counter-ions, nā paʻakai, a me na mea hoohehee koena, no laila hiki i kahi hue ke heluhelu 98% maʻemaʻe a lawe mau i ka peptide liʻiliʻi ma ke kaumaha (Clara Science, 2026). E noi i nā helu ʻelua, me ka chromatogram annotated a me ka spectrum deconvoluted, ma mua o kou ʻae ʻana i ka nui.

Hooia moho peptide: 5-Ke alakaʻi hōʻoia pae

Kākoʻo ʻo MOL Changes i kēia pae me ka mana hōʻoia hōʻoia e hoʻohui i ka hōʻoia ʻike me ka palapala maʻemaʻe.

Ke kahua 2: E ho'āʻo i ka pelu ʻana a me ka hana lua me CD

Me ka ʻike a me ka maʻemaʻe i hoʻomaʻemaʻe ʻia, ʻO ka nīnau aʻe inā hoʻohana ka peptide i ke ʻano āu i hoʻolālā ai. ʻO Far-UV circular dichroism ka heluhelu wikiwiki loa ma kēlā, a me kona nā pūlima CD mamao-UV he mau papa. Hōʻike ka α-helix i ka minima maikaʻi ʻole kokoke 208 a 222 nm me kahi pūna maikaʻi ikaika ma 190-192 nm. Hōʻike ka β-pepa i kahi kāʻei maikaʻi ʻole kokoke i 215–217 nm a me kahi pūʻai maikaʻi kokoke 195 nm. Hōʻike ʻia kahi kaʻina hana ʻino i ka liʻiliʻi maikaʻi ʻole ma 195-200 nm me kahi hōʻailona nāwaliwali kokoke 220 nm.

E heluhelu i kēlā mau pūlima i mea hōʻike, ʻaʻole hōʻoia. Hoʻihoʻi ka Deconvolution i nā manaʻo manaʻo o ka maʻiʻo pili kiʻekiʻe, ʻaʻole kūkulu pae koena, a hoʻomaikaʻi ka pololei ke hōʻiliʻili ʻia ka ʻikepili i 178 nm a haʻahaʻa paha, no ka mea, holo ka ʻāina ʻike mai 180 i 230 nm (he aha ka CD deconvolution hiki a hiki ʻole ke hoʻoholo). Hoʻololi ka haku mele i ka spectrum, wai wai me ka TFE, SDS, a i ʻole nā ​​kūlana DPC ma ka hōʻike me ka hopena.

Pono ka inoa mua o kekahi ʻano hemahema: no nā hoʻolālā i hoʻokaʻawale ʻia, ka liʻiliʻi ikaika ma 195-200 nm me ka nāwaliwali 222 Ua kūlike ka hōʻailona nm me ke kūlana i manaʻo ʻia a ʻaʻole pono e helu ʻia ma ke ʻano he hāʻule pelu. ʻOi aku ka paʻakikī o nā kaʻina i hui ʻia a i ʻole kekahi hapa, a ʻo kā lākou wehewehe ʻana e noho pohihihi ana me ka ʻole o nā ʻano hoʻohui.

Ke kahua 3: Ana kūpaʻa, ka hui ʻana, a me ka hui pu ana

he lāʻau hoʻoholo palapala ʻāina i kēlā me kēia nīnau hui - hapa monomer, nui hydrodynamic, kūlana kūʻokoʻa, nā ʻāpana ʻike ʻia, hana ʻana o ka fibril -

ʻO ka hui ʻana kahi e hūnā ai i nā hemahema o ka pae hope, no laila e hoʻohālikelike i ke ʻano me ka nīnau. No ka hakina monomer, Hōʻike ʻo SEC i ka māhele nui ʻike, akā hiki i ka dilution kolamu ke hoʻololi i ka equilibria nāwaliwali. Hāʻawi ʻo DLS i ka radius hydrodynamic a me ka polydispersity akā ke hoʻohālikelike ʻia i nā mea hoʻopuehu nui loa. Ana ʻo AUC i ka sedimentation i ka hoʻonā manuahi a pale i ka hoʻoheheʻe ʻana o ke kolamu. Loaʻa i ka turbidity nā ʻāpana macroscopic wale nō, a hōʻike ʻo ThT i nā kinetics cross-β fibrillar wale nō, no laila, ʻaʻole e kāpae ka hōʻailona ThT haʻahaʻa i nā ʻano hui ʻē aʻe. ʻO ke koho ʻana i kahi ala hoʻohui orthogonal ʻo ia ka holo ʻana i ʻelua o kēia mau mea, ʻaʻole hoʻokahi. Hoʻopili iā lākou me I Q1A(R2) kūlana hoʻokēʻai: 40 °C ± 2 °C / 75% RH ± 5% RH no ʻeono mahina, a 25 °C ± 2 °C / 60% RH ± 5% RH kahi i kūpono i ka ʻāpana. ʻO ka hana hou 4/25/40 ʻO ka panel °C a me ka 0.1–3% H₂O₂ oxidation pai paʻa i ka ICH a me nā palapala hoʻokumu maʻamau., ʻaʻole nā ​​haʻawina peptide kūʻokoʻa, no laila e mālama iā lākou ma ke ʻano he mea paʻa e hoʻāpono, aole hooilina.

Ke kahua 4: E holo i nā ho'āʻo hana me ka paepae i ʻōlelo ʻia

He mea ʻole ka helu haʻawina a hiki i kou hoʻoponopono ʻana i ka ʻoki ʻoki ʻia i ana ʻia. I hoʻokahi 2025 Nā holomua ʻepekema ke aʻo ʻana i nā peptides i hana ʻia, me ka pili 18.5% hiki i ka hana in vitro ikaika, oiai e pili ana 38.9% Ua wehe ʻia kahi paepae MIC ʻoi aku ka maikaʻi. ʻIke like, ʻelua helu kūleʻa, a ʻo ka mea i hoʻololi ʻia ʻo ia ka wehewehe ʻana o kahi pass.

ʻO ia ke kumu o ka 19% kiʻi mai Watson et al.'s RFdiffusion work in ʻAno pono e heluhelu ʻia ma kāna wehewehe ʻana: e pili ana ma luna a i ʻole 50% o ka pane hoʻomalu maikaʻi loa, ana ʻia e ka helu hoʻokahi BLI ma 10 µM. He mea paʻa ia, ʻaʻole ka helu holomua maʻamau.

E hoʻopaʻa inoa i ʻekolu mau mea ma mua o kou holo ʻana i kekahi mea: ka hoao ana a me ka heluhelu ana, ka mana maikaʻi, a me ka paepae helu helu. Inter-assay variability benchmarks o 10-15% intra-assay a hiki i 20% inter-assay nā pae kuʻikahi-o-hana, ʻaʻole hoʻokahi kumu hoʻohālike, no laila e hoʻonohonoho i kāu ʻikepili kikoʻī hoʻāʻo.

Ke kahua 5: Hoʻomaʻemaʻe endotoxin, sterility, a me ka manufacturability

he papa i hāʻawi ʻia o nā pae hōʻoia ʻelima me ka hoʻāʻo, ka ʻae ʻana, a me ke ʻano hemahema e hoʻihoʻi i ka moho

ʻO Endotoxin ka ho'āʻo hoʻokuʻu hoʻokahi ʻaʻole hiki iā ʻoe ke kali, a ʻo ka palena o ka ʻae ʻana e pili ana i ka mea e hoʻopā ai ka peptide. Ke hoʻohana nei ka hana peptide pae noiʻi i nā palena endotoxin pae noiʻi: ≤1.0 EU/mg no nā laina kelepona i make ʻole e like me HEK293, HeLa, a me CHO, ≤0.05 EU/mg no nā pūnaewele immune mua me nā monocytes, nā pūpū dendritic, a me nā macrophages, a me 0.1–0.5 EU/mg no nā haʻawina ʻiole i loko o vivo (Mea hoʻomohala proteomics, ʻO ka ʻaoʻao i hoʻopaʻa ʻole ʻia e pili ana i ka maʻiʻo 2024–2026). Pane nā lāʻau lapaʻau injectable i kahi lula ʻokoʻa, 5 EU / kg / hola ma lalo o USP <85>.

ʻAʻole kūʻokoʻa ka ʻokoʻa ma waena o ka pae laina cell a me ka pae mua-immune-cell. ʻO nā helu mīkini ma hope o ka pae paʻa e wehewehe: hoʻokahi intraperitoneal injection o 0.1 µg LPS, me ka pili 1,000 EU, hoʻoulu i ka maʻi hiki ke ana i nā ʻiole, a me ka endotoxin e like me ka haahaa 0.1 EU/mL hoʻomāoʻo i nā pūnaewele dendritic (Mea hoʻomohala proteomics, lā ʻole). ʻO kahi hoʻomākaukau e hele maʻemaʻe i loko o nā cell HEK293 hiki ke hoʻololi i kahi helu monocyte mua a i ʻole DC heluhelu., ʻO ia ke kumu e mālama ai nā hui immunology i ka 0.05 EU/mg tier e like me kā lākou paʻamau ma mua o ka 1.0 EU/mg pae.

⚠️ ʻŌlelo Aʻo: Hoʻokuʻu ʻia ka Endotoxin a ʻaʻole hiki ke hoʻopaneʻe ʻia i ka hopena o kahi hoʻolaha. ʻO kahi pūʻulu i hāʻule i ka palena no kāna noi i manaʻo ʻia ʻaʻole ia he moho hiki iā ʻoe ke hoʻopakele me ka ʻoi aku o ka ʻano; pono e hoʻohui hou ʻia a hoʻomaʻemaʻe hou ʻia.

Ke koho ʻana i ke ʻano LAL kūpono

Hoʻohuihui Peptide Pono ke koho ʻana i ke ʻano LAL ma muli o ka naʻau o kou palena. Heluhelu ʻia nā hoʻokolohua Chromogenic ma 405 nm a helu iho i 0.005 EU/mL, ka mea e uhi ana i ka pūnaʻi-immune-mua a me nā ʻāpana vivo me ka palena. He qualitative a semi-quantitative paha ʻo Gel-clot a kūpono loa i ka nānā wikiwiki ʻana, ʻoiai ke nānā nei nā ʻano turbidimetric i ka hoʻololi ʻana i ka density optical ma luna o ka hopena (Mea hoʻomohala proteomics, lā ʻole). USP <85> gel-clot, turbidimetric, a ʻo nā ʻano chromogenic nā koho compendial āpau, me ka recombinant factor C e ʻae wale ʻia inā kākoʻo ke ala kūpono a me ka hōʻoia; e hoʻomaopopo i kēlā 1 Ua like ka USP EU 1 IU, a ʻo ka dilution kūpono kiʻekiʻe ma hope o MVD = (palena endotoxin × hāpana hāpana) / l, kahi ʻo λ ka ʻike hoʻāʻo i hōʻailona ʻia (USP <85> Ho'āʻo Endotoxins Bacterial, USP 31).

He nīnau kaʻawale ka sterility, ʻaʻole kahi ana endotoxin lua. USP <71> ʻAʻole ʻike ka hoʻāʻo sterility ʻaʻohe ʻāpana endotoxin, palena, a i ʻole MVD, no ka mea, ʻaʻole ia he endotoxin assay (USP <71>, lā ʻole). Holo ʻelua, a hōʻike iā lākou ma ke ʻano he ʻelua pae hoʻokuʻu ʻokoʻa.

E hoʻolālā no ka unahi ma mua o kou pono ʻana

ʻO ka piʻi ʻana o ka milligram-a-kilogram ka piʻi ʻana o nā hui. Holo ka hana ʻike ma ka milligrams i ka grams, neʻe ka hoʻomohala kino i nā kilokani, a pili ka lako kalepa ma nā hoʻolaha pākēneka, me ke koi kalepa e hiki ana i na umi a i ole mau haneri kilokani i kela makahiki i keia makahiki a ma kekahi mau mea e pili ana i na pae metric-ton (Bachem, ʻaoʻao ʻole me nā ʻatikala pili i hoʻopaʻa ʻia 2026). He ala synthesis e hoʻomaʻemaʻe i ka endotoxin a me ka sterility ma 50 ʻAʻole hiki i ka mg ke mālama i kēlā mau kikoʻī ma 5 kg, no laila e hōʻoia e hiki i kāu mea hoʻolako ke lawe i ka haʻahaʻa-endotoxin like, ka mālama pono ʻole ʻana mai nā pūʻulu hōʻike milligram ma o ka hana ʻana i nā kilokilika ma mua o kou hoʻokomo ʻana i kahi papahana i kahi kaʻina..

Ke kahua

Hoao

Ka ʻae ʻana

ʻO ke ʻano hāʻule e hoʻouna ʻO nā Peptides Synthetic hope ka moho

1

ʻO ka ʻike a me ka maʻemaʻe

Ua hōʻoia ʻia ke kaʻina; ʻO ka maʻemaʻe e pili ana i ka spec program

Ke kaʻina hewa a i ʻole ka ʻoki ʻana

2

Ka pelu ana a me ka lua

ʻO ke kiko CD e kūlike me ka hoʻohālikelike i manaʻo ʻia

Hoʻopili hewa ʻia a i ʻole ka hoʻokumu ʻia ʻana o ka coil

3

Paʻa a hoʻohui

ʻAʻohe hōʻuluʻulu a hui pū ʻana ma lalo o nā kūlana assay

Kūleʻa koʻikoʻi, ka ua

4

Ka hana

Hoʻokō ka pane i ka paepae i ʻōlelo ʻia ma ka hoʻāʻo ʻana

ʻAʻole hana a koho ʻole paha

5

Nā lawelawe Endotoxin, sterility, hana hana

Endotoxin i loko o ka papa noi; hale kūʻai USP <71> hala; ala hoʻonui

Hoʻokuʻu i ka endotoxin a i ʻole ka hemahema o ka unahi

Nā hewa maʻamau e hoʻopau i kahi kauoha synthesis

Ka hōʻike ʻana i kahi helu maʻemaʻe me ka ʻole o ke ʻano ma hope. ʻAʻohe manaʻo o ka pākēneka me ka ʻole o ke kolamu, nā pae kelepona, gradient, kahe kahe, manawa holo, a me nā lula hoʻohui i hana, no laila ʻaʻole hiki i ka mea loiloi ke haʻi inā 95% e hōʻike ana i kahi huahana maʻemaʻe a i ʻole kahi kumu waiwai. Hoʻopuka i ke ʻano me ka helu, ʻaʻole hiki ke pale ʻia ka helu.

Ka mālama ʻana i ka ʻāpana HPLC ma ke ʻano he peptide content. Helu pākēneka ʻāpana i nā mea a pau e komo i ka lōʻihi nalu ʻike, me ka wai a me nā counter-ions, no laila e hoʻonui i ka nui o ka peptide i loko o ka vial. E hōʻike i ka ʻike peptide net me ka maʻemaʻe, a haʻi i ka hoʻāʻo i hoʻohana ʻia no ka loaʻa ʻana.

Ka helu ʻana i kahi hoʻolālā ʻino ʻia ma ke ʻano he hoʻopiʻi ʻole ma CD wale nō. ʻO kahi kaʻina i kūkulu ʻia e maʻalahi e nānā ʻia e ka hoʻolālā, a ʻo ka heluhelu ʻana ma ke ʻano he kīnā e hoʻihoʻi i kahi moho kūpono no ka hoʻolālā hou ʻana. E hōʻoia i ka papa hana i manaʻo ʻia ma mua o ka unuhi ʻana i ka spectrum.

Ke holo nei i ka hana ma mua o ka ʻike. Inā ʻaʻole i hōʻoia ʻia ka hāpana, hiki i ka haumia ke hoʻokele i ka hōʻailona a loaʻa ka hopena i ke kaʻina hewa. E wehe mua i ka ʻike, a laila e ana i ka hana.

Hoʻopaneʻe i ka endotoxin a hiki i ka hopena. ʻO ka Endotoxin kahi ho'āʻo hoʻokuʻu-pale, ʻaʻole he kūlana hope loa, a ʻo ka ʻike ʻana i kahi hemahema ma hope o ka synthesis a me ka hoʻomaʻemaʻe ʻana e hoʻopau i ke kauoha holoʻokoʻa. E hoʻopaʻa koke iā ia e hana i ka hopena. E pili ana

Pehea ke ano o ka moho i hooiaioia

ʻO kahi moho i hōʻoia ʻia ʻo ia ka mea i kākoʻo ʻia nā koi āpau e kahi helu hiki iā ʻoe ke pale aku. Maikaʻi: he nui paʻa i loko o ka puka makani ppm āu i hoʻonoho ai ma mua o ka holo, he kiʻi maʻemaʻe i hōʻike ʻia me ke ʻano i hana ai, a me kahi spectrum CD e pili ana i ka paʻi a i ʻole ka maʻi āu i manaʻo ai ma mua o kahi kikoʻī āu i noʻonoʻo ai ma hope o ka ʻoiaʻiʻo. E hoʻohui i kahi hakina monomer me kahi ʻaoʻao paʻa wikiwiki, he hopena hana i ana ʻia me ka paepae i kākau mua ʻia, a me ka hopena o ka endotoxin a me ka sterility i loko o ka pae i kūpono i ka hoʻohana i manaʻo ʻia. ʻO kēlā pūʻolo ka mea e hōʻoia ai ka moho peptide.

ʻO ka pahuhopu hoʻolōʻihi he haʻawina hoʻohaʻahaʻa koi ʻia e kapa ana i ke ala hoʻohaʻahaʻa mua ma mua o kou hoʻohiki ʻana i ka hoʻonui ʻana..

Nā ʻanuʻu aʻe

E paipai i nā moho i wehe i nā puka ʻelima: ʻike a me ka maʻemaʻe, pelu ana, kūpaʻa, hana kūʻē i kahi paepae i ʻōlelo ʻia, a me ka endotoxin, sterility, a me nā hōʻoia hana hana. E hoʻopaʻa i nā mea ʻē aʻe a hiki i ka hoʻāʻo hou ʻana o ka puka hāʻule me ka ʻae ʻoi aku ka paʻa, ʻaʻole he mea looser. Hoʻololi kēlā lula hoʻokahi i ka hōʻoia ʻana o ka moho peptide mai kahi pāʻani pāʻani pākahi i kahi pale hoʻihoʻi, a ʻo ia ka hoʻoholo i kūkulu ʻia ai kēia alakaʻi e kākoʻo.

Inā makemake ʻoe e holo nā ʻīpuka ʻelima ma kāu mau kaʻina ponoʻī, kamaʻilio me kā mākou hui analytical e pili ana i kahi ʻōlelo hōʻoia.

Hōʻike: Loaʻa i ka MOL Changes kahi hoihoi pāʻoihana i nā kūlana maikaʻi peptide. Hana ʻia ʻo Peptide

Bingyan Gao

Bingyan Gao

Mea Hana Pono a me Analytical Kaʻike kumu: ʻO ka hoʻokaʻawale ʻana a me ka ʻike ʻana i nā ʻano haumia, Hoʻomohala ʻano hana HPLC/MS, ka hoʻomaʻemaʻe kiral, a me ka hoʻokō ʻana i nā pharmacopoeias honua.

Pilikino: ʻO Bingyan Gao ka "puka kiaʻi hope" o ka maʻemaʻe peptide a me ka maikaʻi. Maikaʻi ʻo ia i ka hoʻohana ʻana i nā mea analytical kiʻekiʻe kiʻekiʻe a loea i ka hoʻomohala ʻana i nā ʻano hoʻokaʻawale chromatographic maʻamau no nā peptides hoʻololi paʻakikī.. Ua hoʻokumu ʻo ia i kahi ʻōnaehana hoʻomaʻemaʻe pono ʻole e hōʻoia i ka maʻemaʻe o ka huahana 99% a i ʻole kiʻekiʻe aʻe akā ʻike pono a hoʻopau i nā ʻano haumia i hiki ke hoʻoulu i ka immunogenicity. Me ka hoʻomaopopo hohonu ʻana i nā koi hoʻoponopono FDA a me EMA no nā lāʻau peptide, hōʻoia ʻo ia ʻo kēlā me kēia pūʻulu i hoʻokuʻu ʻia mai ka hale hana e hele pū ʻia me kahi palapala hōʻoia o ka ʻike ʻana (COA).

ʻIke ʻia & Nā alakaʻi hoʻoponopono
Nānā ʻia e: Ka poe akamai kumuhana
Kaʻana like i kēia ʻatikala
Home Huli Whatsapp Nā lawelawe Huahana